Literature DB >> 21658774

Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.

Isaac I Bogoch1, Benjamin T Davis, Nagagopal Venna.   

Abstract

HIV-associated neurocognitive disorders (HAND) are a group of conditions ranging from asymptomatic neurocognitive impairment to disabling dementia. The clinical spectrum and pathogenesis of these disorders is changing in the era of highly active antiretroviral therapy (HAART). High levels of HIV may exist in the cerebrospinal fluid (CSF) of some patients despite suppression of serum viral loads by HAART. We report a case of a 51-year-old male with profound levels of HIV in the CSF despite low serum levels. Adjusting his HAART regimen based on HIV genotype susceptibility data and a CNS Penetrating Effectiveness (CPE) score resulted in a dramatic improvement in cognitive function. Progressive dementia in this context is a rare but emerging trend and may be reversible.
Copyright © 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658774     DOI: 10.1016/j.jinf.2011.05.011

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  16 in total

1.  Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics.

Authors:  Sergio M de Almeida; Michelli F Oliveira; Antoine Chaillon; Indianara Rotta; Clea E Ribeiro; Ana Paula de Pereira; Davey Smith; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2018-09-07       Impact factor: 2.643

2.  Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape.

Authors:  Sérgio Monteiro de Almeida; Indianara Rotta; Ana Paula de Pereira; Bin Tang; Anya Umlauf; Cléa Elisa Lopes Ribeiro; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2020-01-30       Impact factor: 2.643

Review 3.  Glutamate metabolism and HIV-associated neurocognitive disorders.

Authors:  Fabián J Vázquez-Santiago; Richard J Noel; James T Porter; Vanessa Rivera-Amill
Journal:  J Neurovirol       Date:  2014-05-28       Impact factor: 2.643

4.  Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.

Authors:  Shiping Zou; Sylvia Fitting; Yun-Kyung Hahn; Sandra P Welch; Nazira El-Hage; Kurt F Hauser; Pamela E Knapp
Journal:  Brain       Date:  2011-11-18       Impact factor: 13.501

5.  Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Authors:  Michael J Peluso; Francesca Ferretti; Julia Peterson; Evelyn Lee; Dietmar Fuchs; Antonio Boschini; Magnus Gisslén; Nancy Angoff; Richard W Price; Paola Cinque; Serena Spudich
Journal:  AIDS       Date:  2012-09-10       Impact factor: 4.177

6.  Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.

Authors:  Sergio M de Almeida; Indianara Rotta; Clea E Ribeiro; Michelli F Oliveira; Antoine Chaillon; Ana Paula de Pereira; Ana Paula Cunha; Marise Zonta; Joao França Bents; Sonia M Raboni; Davey Smith; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2017-02-28       Impact factor: 2.643

Review 7.  Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.

Authors:  Francesca Ferretti; Magnus Gisslen; Paola Cinque; Richard W Price
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

Review 8.  Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Authors:  Andrea Calcagno; Giovanni Di Perri; Stefano Bonora
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

9.  Incidence of symptomatic CSF viral escape in HIV infected patients receiving atazanavir/ritonavir (ATV/r)-containing ART: a tertiary care cohort in western India.

Authors:  Atul K Patel; Ketan K Patel; Swati Gohel; Ambuj Kumar; Scott Letendre
Journal:  J Neurovirol       Date:  2018-04-24       Impact factor: 2.643

Review 10.  Immune activation in the central nervous system throughout the course of HIV infection.

Authors:  Serena S Spudich
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.